Set the Tone for Success: Managing Your Acute Coronary Syndrome Clinical Trial

Acute coronary syndrome (ACS) – including unstable angina (UA), non–ST-segment elevation myocardial infarction (NSTEMI), and ST-segment elevation myocardial infarction (STEMI) – demands a rapid response. Blood flow to the heart is suddenly blocked or significantly reduced, and unless blood flow can be restored quickly, the consequences for the patient can range from severely debilitating to fatal.

So where are you working in the realm of ACS research? You could be looking for ways to lessen the threat of the atherosclerotic plaques that often rupture and cause the arterial blockage. You could be looking at ways to diagnose the precipitating event more quickly and intervene more rapidly when a cardiovascular event occurs. In any ACS research scenario, you need access to people who can help you prove the efficacy of the therapy you are developing. You need access to medical facilities that routinely encounter ACS and to clinicians who are willing to help you further your work, even while they attend to the real-time demands of patients experiencing one of these painful, life-threatening events.

Worldwide Clinical Trials has been partnering with cardiology researchers, including work with novel chemical entities and devices, for more than 30 years. We are the experts in managing clinical trials focusing on ACS – whether those are small-scale Phase I trials or complex, global Phase IV trials. Looking to take the next step with real-world evidence? We’ve got you covered there, too.

When you need a stable team of project professionals who already have experience in cardiovascular research, who can provide you with insightful feedback on development plans, detailed and expert feasibility analyses, and who have the resources and management skills to deliver your project on time and on budget, look no further than Worldwide.